共查询到20条相似文献,搜索用时 31 毫秒
1.
Blockade of chemokines or chemokine receptors is emerging as a new potential treatment for various immune-mediated conditions.
This review focuses on the therapeutic potential in rheumatoid arthritis, based on studies in animal models and patients.
Several knockout models as well as in vivo use of chemokine antagonists are discussed. Review of these data suggests that this approach might lead to novel therapeutic
strategies in rheumatoid arthritis and other chronic inflammatory disorders. 相似文献
2.
Feldmann M 《Nature reviews. Immunology》2002,2(5):364-371
The aetiology of systemic, autoimmune, chronic inflammatory diseases--such as rheumatoid arthritis--is not known, and their pathogenesis is complex and multifactorial. However, progress in the characterization of intercellular mediators--proteins that are now known as cytokines--has led to the realization that one cytokine, tumour-necrosis factor (TNF; previously known as TNF-alpha), has an important role in the pathogenesis of rheumatoid arthritis. This discovery heralded a new era of targeted and highly effective therapeutics for rheumatoid arthritis and, subsequently, other chronic inflammatory diseases. 相似文献
3.
The present case–control study was conducted to investigate the relationship between smoking and rheumatoid arthritis, and
to investigate formally the interaction between sex, smoking, and risk for developing rheumatoid arthritis. The study was
performed in the Central District of Finland. Cases were patients with rheumatoid arthritis and the control group was a random
sample of the general population. Logistic regression models were used to evaluate the effect of smoking on risk for rheumatoid
arthritis, after adjusting for the effects of age, education, body mass index, and indices of general health and pain. Overall,
1095 patients with rheumatoid arthritis and 1530 control individuals were included. Patients were older, less well educated,
more disabled, and had poorer levels of general health as compared with control individuals (all P < 0.01). Preliminary analyses revealed the presence of substantial statistical interaction between smoking and sex (P < 0.001). In separate multivariable analyses, past history of smoking was associated with increased risk for rheumatoid arthritis
overall in men (odds ratio 2.0, 95% confidence interval 1.2–3.2) but not in women. Among men, this effect was seen only for
rheumatoid factor-positive rheumatoid arthritis. There were significant interactions between smoking and age among women but
not among men. We conclude that sex is a biologic effect modifier in the association between smoking and rheumatoid arthritis.
The role of menopause in the etiology of rheumatoid arthritis merits further research. 相似文献
4.
IL-17作为前炎症因子参与类风湿关节炎,系统性红斑狼疮等自身免疫性疾病的病理过程。它主要由CD4+T细胞的一个亚群--Th17细胞分泌释放。目前,IL-17在类风湿关节炎的病理过程中的作用引起了医学界广泛的关注,抗IL-17A抗体已经生产并进入临床实验,用于治疗类风湿关节炎、银屑病关节炎等疾病。但其在类风湿关节炎病理过程中的作用尚需进一步研究,其有效性亦尚需进一步探讨。本文主要针对IL-17家族的各个亚型的表达、调控、生物学作用及与类风湿关节炎发病的关系进行阐述,为类风湿关节炎的治疗提供新的思路。 相似文献
5.
Liljander M Sällström MA Andersson S Andersson A Holmdahl R Mattsson R 《Arthritis research & therapy》2006,8(2):R45-6
Collagen-induced arthritis in mice is one of the most commonly used autoimmune experimental models, with many similarities
to rheumatoid arthritis. Since collagen-induced arthritis is a complex polygenic disease there is a need for identification
of several major disease-controlling genes. Because rheumatoid arthritis particularly affects aged women, we have in the present
study identified new genetic regions critical for collagen-induced arthritis by studying aged female mice of a cross between
NFR/N and B10.Q (H-2q haplotype). The mice in the present study had different reproductive histories, which did not significantly affect the onset,
incidence or severity of the disease. A total of 200 female mice were used in a total genome-wide screening with 125 microsatellite
markers. We found one new significant quantitative trait locus affecting the arthritis incidence, severity and day of onset
on chromosome 11 (denoted Cia40), which colocalizes with a locus controlling pregnancy failure. Furthermore, a quantitative trait locus of suggestive significance
associated with the incidence, severity and day of onset was identified on chromosome 1. Finally, a suggestively significant
quantitative trait locus associated with collagen type II antibody titers was identified on chromosome 13. This study indicates
that several gene loci control arthritis in aged multiparous females, and that at least one of these loci coincides with pregnancy
failure. 相似文献
6.
Rat adjuvant arthritis (AA) is an animal model of rheumatoid arthritis in which pannus formation and destruction of joints occur after immunization with complete Freund's adjuvant. Neovascularization is present within the synovium and may be critical for pannus growth. In this study the effects of a novel angiogenesis inhibitor, AGM-1470, on AA were evaluated. Lewis rats were immunized with CFA to induce arthritis. AGM-1470 treatment was initiated prior to arthritis onset (preventative protocol) or administered to rats with established disease (suppressive protocol). The severity of synovitis and the immunologic status of all rats were then evaluated. Using clinical and radiographic criteria, AGM-1470 significantly reduced arthritis incidence (preventative protocol) (P < 0.01) and disease severity (both protocols, P < 0.001, compared to controls) without affecting T cell function in vitro or phenotype in vivo. Additionally, histologic sections from control rats revealed marked pannus formation, destruction of bone/cartilage, and neovascularization. These findings were absent in AGM-1470-treated rats. AGM-1470 may offer a new treatment option for rheumatoid arthritis and other angiogenesis-dependent diseases. 相似文献
7.
Introduction
There is an ever-increasing need for animal models to evaluate efficacy and safety of new therapeutics in the field of rheumatoid arthritis (RA). Particularly for the early preclinical evaluation of human-specific biologicals targeting the progressive phase of the disease, there is a need for relevant animal models. In response to this requirement we set out to develop a model of collagen-induced arthritis (CIA) in a small-sized nonhuman primate species (300 to 400 g at adult age); that is, the common marmoset (Callithrix jacchus). 相似文献8.
Wei CC Hsu YH Li HH Wang YC Hsieh MY Chen WY Hsing CH Chang MS 《Journal of biomedical science》2006,13(5):601-612
Summary IL-20 belongs to the IL-10 family and plays a role in skin inflammation and the development of hematopoietic cells. Little is known about its other biological functions and clinical implications, however. Updated information about IL-20, such as its identification, expression, receptors, signaling, biological activities, and potential clinical implications, is illustrated in this review based on our research and on data available in the literature. Our studies of IL-20 show that it is a pleiotropic cytokine with potent inflammatory, angiogenic, and chemoattractive characteristics. Inflammation and angiogenesis are essential for the pathogenesis of rheumatoid arthritis and atherosclerosis. Based on in vitro data and clinical samples, we demonstrated that IL-20 is involved in the diseases of rheumatoid arthritis and atherosclerosis. In addition, we found in our studies that IL-20 signaled through different molecules in several cells. The present review presents the clinical implications of IL-20 in rheumatoid arthritis and atherosclerosis. It may provide new therapeutic options in the future.This work was supported by a grant from Chi-Mei Medical Center, Tainan, Taiwan. 相似文献
9.
In the previous issue of Arthritis Research & Therapy data are presented showing that circulating immune complexes containing citrullinated fibrin(ogen) are present in anti-citrullinated
protein antibody-positive rheumatoid arthritis patients, and that such immune complexes co-localize with complement factor
C3 in the rheumatoid synovium. These results corroborate the idea that citrullination is intimately involved in the pathophysiology
of rheumatoid arthritis and complete our model (the rheumatoid arthritis cycle) for the development and chronic nature of
this disease. 相似文献
10.
For female patients with rheumatoid arthritis, the availability of a host of new disease modifying antirheumatic drugs has
raised important questions about fetal safety if a woman becomes pregnant while she is being treated. In addition, there is
limited safety information regarding many of the older medications commonly used to treat rheumatoid arthritis in women of
reproductive age. Current summary pregnancy risk information for selected medications used to treat rheumatoid arthritis is
reviewed in the context of the pregnancy label category. In addition, the strengths and weaknesses of post-marketing strategies
for developing new pregnancy safety information are described. 相似文献
11.
Jin P Zhang J Sumariwalla PF Ni I Jorgensen B Crawford D Phillips S Feldmann M Shepard HM Paleolog EM 《Arthritis research & therapy》2008,10(4):R73
Introduction
Despite the advent of biological therapies for the treatment of rheumatoid arthritis, there is a compelling need to develop alternative therapeutic targets for nonresponders to existing treatments. Soluble receptors occur naturally in vivo, such as the splice variant of the cell surface receptor for vascular endothelial growth factor (VEGF) – a key regulator of angiogenesis in rheumatoid arthritis. Bioinformatics analyses predict that the majority of human genes undergo alternative splicing, generating proteins – many of which may have regulatory functions. The objective of the present study was to identify alternative splice variants (ASV) from cell surface receptor genes, and to determine whether the novel proteins encoded exert therapeutic activity in an in vivo model of arthritis. 相似文献12.
Winchester R 《Arthritis research & therapy》2006,8(3):109-3
This issue of Arthritis Research and Therapy contains a succinct and elegant paper by Michou and colleagues that advances our understanding of the genetic basis of rheumatoid
arthritis (RA) by reclassifying the contribution of RA susceptibility alleles according to their structure. This line of research
is potentially important in our conceptualization of the mechanism of disease in RA, in predicting disease course and severity,
and as a model for further studies on this topic. The author's approach to reassessing the molecular structure of the shared
epitope redirects attention to using the binding properties of the major histocompatibility complex molecules associated with
susceptibility to search for the peptides driving the autoimmune process underlying rheumatoid arthritis 相似文献
13.
Mattyasovszky S Skapenko A Kalden JR Lipsky PE Schulze-Koops H 《Arthritis research & therapy》2006,8(3):R63-3
On the basis of their biological function, potential genetic candidates for susceptibility to rheumatoid arthritis can be
postulated. IFNGR1, encoding the ligand-binding chain of the receptor for interferon gamma, IFNγR1, is one such gene because interferon gamma
is involved in the pathogenesis of the disease. In the coding sequence of IFNGR1, two nucleotide positions have been described to be polymorphic in the Japanese population. We therefore investigated the
association of those two IFNGR1 single nucleotide polymorphisms with rheumatoid arthritis in a case-control study in a central European population. Surprisingly,
however, neither position was polymorphic in the 364 individuals examined, indicating that IFNGR1 does not contribute to susceptibility to rheumatoid arthritis, at least in Caucasians. 相似文献
14.
The present case-control study was conducted to investigate the relationship between smoking and rheumatoid arthritis, and to investigate formally the interaction between sex, smoking, and risk for developing rheumatoid arthritis. The study was performed in the Central District of Finland. Cases were patients with rheumatoid arthritis and the control group was a random sample of the general population. Logistic regression models were used to evaluate the effect of smoking on risk for rheumatoid arthritis, after adjusting for the effects of age, education, body mass index, and indices of general health and pain. Overall, 1095 patients with rheumatoid arthritis and 1530 control individuals were included. Patients were older, less well educated, more disabled, and had poorer levels of general health as compared with control individuals (all P < 0.01). Preliminary analyses revealed the presence of substantial statistical interaction between smoking and sex (P < 0.001). In separate multivariable analyses, past history of smoking was associated with increased risk for rheumatoid arthritis overall in men (odds ratio 2.0, 95% confidence interval 1.2-3.2) but not in women. Among men, this effect was seen only for rheumatoid factor-positive rheumatoid arthritis. There were significant interactions between smoking and age among women but not among men. We conclude that sex is a biologic effect modifier in the association between smoking and rheumatoid arthritis. The role of menopause in the etiology of rheumatoid arthritis merits further research. 相似文献
15.
L. Dai D.J. Lamb D.S. Leake M.L. Kus H.W. Jones C.J. Morris 《Free radical research》2013,47(6):479-486
The oxidative modification of human LDL has been implicated in atherosclerosis, but the mechanisms by which such modification occurs in vivo are not fully understood. In the present study, we have isolated LDL from knee-joint synovial fluid of patients with rheumatoid arthritis. We demonstrate that such LDL is oxidatively modified as evidenced by an increased negative charge, distorted particulate nature and more rapid degradation by cultured macrophages. These results indicate that formation of oxidised LDL is associated with the local inflammatory response. Because the cellular interactions in rheumatoid arthritis have analogies with those in atherogenesis, we suggest that the rheumatoid joint is a useful model of atherosclerosis in which the in vivo process of LDL oxidation may be readily studied. 相似文献
16.
Autoimmune diseases such as rheumatoid arthritis and gastrointestinal disorders such as stomach ulcers are often treated with
drugs. NSAIDs, a common treatment in rheumatoid arthritis, may cause stomach ulcers which call for additional medications,
notably antacids in the sense of drugs that suppress acid secretion by the stomach. Infection with Helicobacter pylori also plays a role in the ulcers. The infection is typically treated with antibiotics added to antacids. Considering NSAIDs
and antacids, we suspect that overmedication is common to the extent that particular diets are a better option. Current research
and current treatments with these drugs are also problematic since circadian rhythms are mostly disregarded. All the processes
involved in the disorders treated show marked variations in the course of the day. Hence experiments conforming to the guidelines
of evidence-based medicine, and treatments in line with them, have outcomes strongly depending on the time factor. This calls
for reforms in medicine with fresh inputs from biology. 相似文献
17.
Using chemiluminescence to determine whole blood antioxidant capacity in rheumatoid arthritis and Parkinson's disease patients
下载免费PDF全文
![点击此处可从《Luminescence》网站下载免费的PDF全文](/ch/ext_images/free.gif)
The consequences of oxidative stress and inflammation are implicated in a wide range of diseases, including rheumatoid arthritis and Parkinson's disease. The status of antioxidant capacity in rheumatoid arthritis and Parkinson's disease remains unclear, in part due to common practice of assaying erythrocytes separately to plasma. This method removes any synergistic interactions between plasma and erythrocyte‐based antioxidants. The experiments in this report tested antioxidant capacity in whole blood, erythrocytes and plasma by group and disease stage. Medically diagnosed patients were recruited along with appropriate control group participants. Fasting venous blood was assayed using chemiluminescence methods for: time to maximum light emitted, maximum light emitted, and plasma antioxidant capacity in vitamin E analogue units. Here we demonstrate that whole blood exhibits higher antioxidant capacity than either plasma or erythrocytes assayed separately. We report increased oxidative stress in the blood of rheumatoid arthritis patients by group (p = 0.018, p = 0.049). We show increased antioxidant capacity in Parkinson's disease patients by group (p < 0.001). For later stage Parkinson's disease patients, we report reduced oxidative stress (p = 0.025), and increased antioxidant capacity and for erythrocytes (p < 0.001, p = 0.004) and whole blood (p < 0.001, p = 0.003). Early stage Parkinson's disease showed higher antioxidant capacity on only one measure (p = 0.008). Whole blood chemiluminescence is a useful technique for determining redox status in disease and might help clarify the role of oxidative stress in rheumatoid arthritis and Parkinson's disease. 相似文献
18.
Rikard Holmdahl Carina Vingsbo-Lundberg Niklas Nordquist Peter Olofsson Mats Sundvall Tore Saxne Ulf Pettersson 《Journal of Experimental Animal Science》2000,41(1-2)
This study was specifically designed to analyse the genetic control of the chronic disease course for the development of arthritis. Arthritis models with a chronic erosive arthritis are collagen induced arthritis induced with homologous collagen in oil but also arthritis induced with certain non-immunogenic adjuvants such as pristane and avridine. In the presently described experiment we have used pristane induced arthritis. A single injection of 150 μl pristane induces severe chronic arthritis in DA rats. The disease mimics rheumatoid arthritis in many aspects such as the chronic disease course, an erosive inflammation of peripheral joints, symmetric involvement of the joints and the development of rheumatoid factors. To determine the genetic contribution we have used a number of inbred, recombinant inbred and congenic strains as well as specifically designed segregating crosses. An influence by the MHC region (designated Pia1 locus) on the chronic disease course was determined through the uses of MHC congenic LEW strains in which the RT1-f haplotype conferred highest susceptibility. To map genes outside of MHC we used an F2 cross between the highly susceptible DA and the resistant E3 strains. Loci exclusively associated with different phenotypes of the disease could be identified:
- Arthritis onset (Pia2 and Pia3).
- Severity and joint erosions (Pia4).
- Chronicity (Pia5 and Pia6) and Pia1 (determined from MHC congenic (strains)
19.
A Davidson M B Van der Weyden H Fong M J Breidahl P F Ryan 《BMJ (Clinical research ed.)》1984,289(6446):648-650
In iron deficiency anaemia basic red cell content of ferritin is appreciably reduced. This variable was determined in 62 patients with rheumatoid arthritis to evaluate conventional laboratory indices for iron deficiency in the anaemia of rheumatoid arthritis. For 23 patients with rheumatoid arthritis and normocytic anaemia irrespective of plasma ferritin concentration, red cell ferritin content did not differ significantly from that for non-anaemic patients with rheumatoid arthritis. For 27 patients with rheumatoid arthritis and microcytic anaemia, the mean red cell ferritin content for patients with a plasma ferritin concentration in the 13-110 micrograms/l range was appreciably reduced. It was indistinguishable from that for patients with rheumatoid arthritis and classical iron deficiency anaemia, indicated by plasma ferritin concentrations of less than 12 micrograms/l. In contrast, the mean red cell ferritin content for patients with rheumatoid arthritis, microcytic anaemia, and plasma ferritin concentrations above 110 micrograms/l did not differ from that for patients with rheumatoid arthritis and normocytic anaemia. Oral treatment with iron in patients with rheumatoid arthritis, microcytic anaemia, and appreciably reduced red cell ferritin concentrations was accompanied by significant increases in haemoglobin concentration (p less than 0.01), mean corpuscular volume (p less than 0.01), and red cell ferritin contents (p less than 0.05). This treatment, however, did not produce any appreciable change in haemoglobin concentration in patients with rheumatoid arthritis, normocytic anaemia, and normal red cell ferritin contents. These findings suggest that the indices for iron deficiency in patients with rheumatoid arthritis and anaemia should include peripheral blood microcytosis together with a plasma ferritin concentration of less than 110 micrograms/l. 相似文献
20.
Chiang EP Selhub J Bagley PJ Dallal G Roubenoff R 《Arthritis research & therapy》2005,7(6):R1404-R1411
Patients with rheumatoid arthritis have subnormal vitamin B6 status, both quantitatively and functionally. Abnormal vitamin
B6 status in rheumatoid arthritis has been associated with spontaneous tumor necrosis factor (TNF)-α production and markers
of inflammation, including C-reactive protein and erythrocyte sedimentation rate. Impaired vitamin B6 status could be a result
of inflammation, and these patients may have higher demand for vitamin B6. The aim of this study was to determine if daily
supplementation with 50 mg of pyridoxine for 30 days can correct the static and/or the functional abnormalities of vitamin
B6 status seen in patients with rheumatoid arthritis, and further investigate if pyridoxine supplementation has any effects
on the pro-inflammatory cytokine TNF-α or IL-6 production of arthritis. This was a double-blinded, placebo-controlled study
involving patients with rheumatoid arthritis with plasma pyridoxal 5'-phosphate below the 25th percentile of the Framingham
Heart Cohort Study. Vitamin B6 status was assessed via plasma and erythrocyte pyridoxal 5'-phosphate concentrations, the erythrocyte
aspartate aminotransferase activity coefficient (αEAST), net homocysteine increase in response to a methionine load test (ΔtHcy),
and 24 h urinary xanthurenic acid (XA) excretion in response to a tryptophan load test. Urinary 4-pyridoxic acid (4-PA) was
measured to examine the impact of pyridoxine treatment on vitamin B6 excretion in these patients. Pro-inflammatory cytokine
(TNF-α and IL-6) production, C-reactive protein levels and the erythrocyte sedimentation rate before and after supplementation
were also examined. Pyridoxine supplementation significantly improved plasma and erythrocyte pyridoxal 5'-phosphate concentrations,
erythrocyte αEAST, urinary 4-PA, and XA excretion. These improvements were apparent regardless of baseline B6 levels. Pyridoxine
supplementation also showed a trend (p < 0.09) towards a reduction in post-methionine load ΔtHcy. Supplementation did not affect pro-inflammatory cytokine production.
Although pyridoxine supplementation did not suppress pro-inflammatory cytokine production in patients with rheumatoid arthritis,
the suboptimal vitamin B6 status seen in rheumatoid arthritis can be corrected by 50 mg pyridoxine supplementation for 30
days. Data from the present study suggest that patients with rheumatoid arthritis may have higher requirements for vitamin
B6 than those in a normal healthy population. 相似文献